Group 1 - The core point of the article is that Changqing Technology plans to raise funds through convertible bonds for capacity expansion, marking its first refinancing effort since its IPO two years ago [1][2] - The company intends to issue convertible bonds totaling no more than 800 million yuan, with the net proceeds aimed at the first phase of the Taizhou high polymer new materials production base [1][2] - The total investment for the Taizhou project is 2.855 billion yuan, with the goal of producing 80,000 tons of trimellitic anhydride, 10,000 tons of isophthalic acid, and 120,000 tons of phenol series products annually [2] Group 2 - Changqing Technology is a high-tech enterprise specializing in the R&D, production, and sales of special monomers and additives for high polymer new materials [1] - The company reported a revenue of 485 million yuan in the first half of 2025, a year-on-year decrease of 10.67%, and a net profit of 70.247 million yuan, down 31.89% year-on-year [2][3] - The average selling prices of its main products, special monomers and additives, decreased by 5.43% and 2.35% respectively, while production and sales volumes also saw significant declines [3]

Core Viewpoint - Jiangsu Changqing Tree New Materials Technology Co., Ltd. reported its fundraising and usage situation for the first half of 2025, highlighting the total amount raised and the allocation of funds for various projects [2][3][4]. Group 1: Fundraising Overview - The company raised a total of RMB 125,067.72 million by issuing 48.14 million shares at a price of RMB 25.98 per share, with a net amount of RMB 113,222.81 million after deducting various fees [2][3]. - The funds were deposited into a dedicated account managed by the main underwriter, Everbright Securities Co., Ltd., on April 3, 2023 [2][3]. Group 2: Fund Usage and Balance - As of June 30, 2025, the company utilized RMB 16,437.49 million of the raised funds for investment projects, with a cumulative usage of RMB 54,705.11 million [3][4]. - The remaining balance of the raised funds was RMB 38,021.13 million, which includes bank interest and investment income [3][4]. Group 3: Fund Management - The company established a management system for the raised funds, ensuring they are stored in dedicated accounts and used in compliance with relevant regulations [4][5]. - A tripartite supervision agreement was signed with the underwriter and banks to ensure proper management of the funds [5]. Group 4: Adjustments to Fund Projects - In 2024, the company adjusted its fundraising investment projects, reducing the investment in certain facilities while increasing it in others, resulting in a net reduction of approximately RMB 3,000 million [14][15]. - The adjustments were made based on market conditions and operational needs, without changing the project name or implementation details [15]. Group 5: Operational Data - The company reported its main operational data for the first half of 2025, including production and sales figures, which reflect the company's performance in the new materials sector [25][26]. - The company noted that the sales volume exceeded production volume due to the purchase of finished products, specifically high polymer new material special monomers [25][26].

江苏常青树新材料科技股份有限公司 2025 年半年度主要经营数据的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 江苏常青树新材料科技股份有限公司（以下简称"公司"）根据上海证券交易 所《上海证券交易所上市公司自律监管指引第 3 号——行业信息披露》有关规定， 将公司 2025 年半年度主要经营数据披露如下： 一、主要产品产量、销售及收入实现情况 单位：吨、万元 | 主要产品 | 2025 | 年 | 1-6 月 | 2025 年 | 1-6 月 | 2025 年 | 1-6 | 月 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | 产量 | | 销量 | | 销售金额 | | | | 高分子新材料特种单体 | | 10,883.38 | | 15,061.18 | | 19,537.06 | | | | 高分子新材料专用助剂 | | 7,264.69 | | 6,635.50 | | 13,391.92 | | | 江苏常青树新材料科技股份有 ...

Investment Rating - The report maintains a "Positive" investment rating for the basic chemical industry [4] Core Viewpoints - The exit of overseas bulk chemicals is expected to accelerate the growth of China's fine chemicals [6][21] - China's petrochemical capacity has rapidly increased since 2018, surpassing the US in refining capacity in 2023, leading to a stronger competitive position compared to Europe and Northeast Asia [15][6] - The reduction in imports of phenol and the expansion of downstream products like PC and epoxy resins in China have significantly decreased overseas demand for phenol, creating opportunities for domestic fine chemical companies [15][6] Summary by Sections 1. Impact of Overseas Bulk Chemical Exit - The exit of European bulk chemical capacity is driven by the rapid enhancement of China's chemical industry competitiveness [10] - China's share in bulk chemicals has been increasing, with significant capital expenditure leading to output growth [10][18] - The exit of marginal capacity in Europe and Japan is expected to accelerate supply-demand balance restoration in the industry [23][24] 2. Opportunities for Domestic Fine Chemicals - China's technological breakthroughs and industry chain expansion are forcing European upstream bulk chemicals to exit [25] - The trend of European chemical industry exit is unlikely to reverse, providing growth opportunities for China's fine chemical enterprises [25][39] - The exit of bulk chemicals will lead to supply issues in fine chemical products, prompting demand for stable suppliers from China [39][44] 3. Investment Recommendations - Recommended companies include: - Huangma Technology (603181, Buy): A leader in specialty polyether with a total capacity of approximately 225,000 tons and new projects adding 330,000 tons [47] - Changqing Technology (603125, Not Rated): A leader in specialty monomers with a projected capacity increase from 35,000 tons to 90,500 tons by the end of 2024 [47] - Lianlong (300596, Buy): A leader in polymer materials with a focus on anti-aging agents and lubricant additives [47]

江苏常青树新材料科技股份有限公司 （Jiangsu Evergreen New Material Technology Incorporated Company） 声明 （镇江新区青龙山路 3 号） 首次公开发行股票并在主板上市 招股说明书 保荐人（主承销商） （上海市静安区新闸路 1508 号） 中国证监会、交易所对本次发行所作的任何决定或意见，均不表明其对发行 人注册申请文件及所披露信息的真实性、准确性、完整性作出保证，也不表明其 对发行人的盈利能力、投资价值或者对投资者的收益作出实质性判断或保证。任 何与之相反的声明均属虚假不实陈述。 根据《证券法》规定，股票依法发行后，发行人经营与收益的变化，由发行 人自行负责；投资者自主判断发行人的投资价值，自主作出投资决策，自行承担 股票依法发行后因发行人经营与收益变化或者股票价格变动引致的投资风险。 1-1-1 本次发行概况 | 发行股票类型 | 人民币普通股（A 股） | | | | | | --- | --- | --- | --- | --- | --- | | 发行股数 | 本次向社会公众公开发行 股）股票； | | | | 4,814.00 万股人民币 ...

江苏常青树新材料科技股份有限公司 （Jiangsu Evergreen New Material Technology Incorporated Company） （镇江新区青龙山路 3 号） 首次公开发行股票并在主板上市 招股意向书 保荐人（主承销商） （上海市静安区新闸路 1508 号） 声明 中国证监会、交易所对本次发行所作的任何决定或意见，均不表明其对发行 人注册申请文件及所披露信息的真实性、准确性、完整性作出保证，也不表明其 对发行人的盈利能力、投资价值或者对投资者的收益作出实质性判断或保证。任 何与之相反的声明均属虚假不实陈述。 根据《证券法》规定，股票依法发行后，发行人经营与收益的变化，由发行 人自行负责；投资者自主判断发行人的投资价值，自主作出投资决策，自行承担 股票依法发行后因发行人经营与收益变化或者股票价格变动引致的投资风险。 1-1-1 本次发行概况 | 发行股票类型 | 人民币普通股（A 股） | | | | --- | --- | --- | --- | | 发行股数 | 本次拟向社会公众公开发行 4,814.00 股）股票； | | 万股人民币普通股（A | | | 本次发行全部为 ...

江苏常青树新材料科技股份有限公司 （Jiangsu Evergreen New Material Technology Incorporated Company） （镇江新区青龙山路 3 号） 首次公开发行股票并在主板上市 招股说明书 （注册稿） 声明：本公司的发行申请尚需经上海证券交易所和中国证监会履行相应程序。本招股说明书 不具有据以发行股票的法律效力，仅供预先披露之用。投资者应当以正式公告的招股说明书 全文作为作出投资决定的依据。 保荐机构（主承销商） （上海市静安区新闸路 1508 号） 声明 中国证监会、交易所对本次发行所作的任何决定或意见，均不表明其对发行 人注册申请文件及所披露信息的真实性、准确性、完整性作出保证，也不表明其 对发行人的盈利能力、投资价值或者对投资者的收益作出实质性判断或保证。任 何与之相反的声明均属虚假不实陈述。 根据《证券法》规定，股票依法发行后，发行人经营与收益的变化，由发行 人自行负责；投资者自主判断发行人的投资价值，自主作出投资决策，自行承担 股票依法发行后因发行人经营与收益变化或者股票价格变动引致的投资风险。 1-1-1 本次发行概况 | 发行股票类型 | 人民币普通 ...

江苏常青树新材料科技股份有限公司 （Jiangsu Evergreen New Material Technology Incorporated Company） （镇江新区青龙山路 3 号） 首次公开发行股票并在主板上市 招股说明书 （申报稿） 声明：本公司的发行申请尚需经上海证券交易所和中国证监会履行相应程序。本招股说明书 不具有据以发行股票的法律效力，仅供预先披露之用。投资者应当以正式公告的招股说明书 全文作为作出投资决定的依据。 保荐机构（主承销商） （上海市静安区新闸路 1508 号） 声明 中国证监会、交易所对本次发行所作的任何决定或意见，均不表明其对发行 人注册申请文件及所披露信息的真实性、准确性、完整性作出保证，也不表明其 对发行人的盈利能力、投资价值或者对投资者的收益作出实质性判断或保证。任 何与之相反的声明均属虚假不实陈述。 根据《证券法》规定，股票依法发行后，发行人经营与收益的变化，由发行 人自行负责；投资者自主判断发行人的投资价值，自主作出投资决策，自行承担 股票依法发行后因发行人经营与收益变化或者股票价格变动引致的投资风险。 1-1-1 本次发行概况 | 发行股票类型 | 人民币普通 ...

江苏常青树新材料科技股份有限公司 （Jiangsu Evergreen New Material Technology Incorporated Company） （镇江新区青龙山路 3 号） 首次公开发行股票并在主板上市 招股说明书 （申报稿） 声明：本公司的发行申请尚需经上海证券交易所和中国证监会履行相应程序。本招股说明书 不具有据以发行股票的法律效力，仅供预先披露之用。投资者应当以正式公告的招股说明书 全文作为作出投资决定的依据。 保荐机构（主承销商） （上海市静安区新闸路 1508 号） 声明 中国证监会、交易所对本次发行所作的任何决定或意见，均不表明其对发行 人注册申请文件及所披露信息的真实性、准确性、完整性作出保证，也不表明其 对发行人的盈利能力、投资价值或者对投资者的收益作出实质性判断或保证。任 何与之相反的声明均属虚假不实陈述。 根据《证券法》规定，股票依法发行后，发行人经营与收益的变化，由发行 人自行负责；投资者自主判断发行人的投资价值，自主作出投资决策，自行承担 股票依法发行后因发行人经营与收益变化或者股票价格变动引致的投资风险。 1-1-1 本次发行概况 | 发行股票类型 | 人民币普通 ...